Bayer CropScience (506285) Q2 24/25 earnings summary

Executive summary

• Unaudited financial results for the quarter and half year ended September 30, 2024, were approved and reviewed by the Board and auditors.

• Interim dividend of ₹90 per equity share declared, payable on December 11, 2024, with a record date of November 26, 2024.

• Mr. Rajaram Mohan Babu Boppana appointed as Senior Management Personnel effective November 14, 2024.

Financial highlights

• Revenue from operations for Q2 FY25 was ₹17,376 million, up from ₹16,172 million in Q2 FY24.

• Profit before tax for Q2 FY25 was ₹1,901 million, compared to ₹2,229 million in Q2 FY24.

• Net profit for Q2 FY25 stood at ₹1,363 million, down from ₹2,229 million in Q2 FY24.

• Earnings per share (basic and diluted) for Q2 FY25 was ₹30.33, compared to ₹49.60 in Q2 FY24.

• Total comprehensive income for Q2 FY25 was ₹1,361 million.

Outlook and guidance

• Business is seasonal; quarterly figures may not represent full-year performance.